There’s more positive CBD news this week as we strive to keep you apprised of many of the most important developments in the dynamic, evolving world of medicinal cannabis.
Excerpts…
“A World Health Organization (WHO) report has found … naturally occurring CBD is safe and well tolerated in humans (and animals), and not associated with any negative public health effects.
…CBD does not induce physical dependence and is ‘not associated with abuse potential,’ [and] unlike THC, people aren’t getting high off of CBD.
…[They further] determined that CBD has ‘been demonstrated as an effective treatment for epilepsy’ in adults, children, and even animals [with] ‘preliminary evidence’ CBD could be useful in Alzheimer’s, Parkinson’s, cancer, psychosis, and other conditions.”
Hmmmmm.
So does this sound like a Schedule 1 narcotic (extreme abuse potential and no medical value) to you, as the DEA has now unilaterally declared all CBD products to be….??
…Yeah, we have trouble digesting that as well.
Which is why we’re awaiting the outcome of the upcoming lawsuit against the DEA’s CBD position (see yesterday’s blog posts) with great interest.
“…in the US, the substance’s mostly unsanctioned and illegal state creates problems, especially as a wave of online and store-bought [hemp] CBD oils and extracts have allowed patients to take the treatment process–and the risks involved in buying unregulated medicine–into their own hands and homes.
While CBD itself is safe and helpful for many, industry experts have warned that not all cannabis extracts are created equally, purely, or with the same methods of extraction.”
So prohibition no, but a testing and regulatory system which assures CBD products are as well-tested as other powerful medicinal agents the public can buy – from Tylenol to dandruff shampoo…
…i.e., patients deserve medicines which don’t make unverified claims and which have been tested for accurate ingredient labeling, purity, contaminants, etc. This is the minimum bottom line of what the public as a whole has the right to expect.
This is not more “waiting for the science,” and not more prohibition, rather it’s just bringing this class of products into the mainstream where they’re both accepted by society AND play by sensible, achievable rules….
…Just as the ballot initiative for full-spectrum cannabis medicines would assure a system of careful oversight for dispensing them as adequate as pharmacies are for pharmaceutical drugs. (Indeed – to answer critic’s fears – the initiative calls for even tighter regulation than most pharmaceuticals face.) (And it’s a start that can be built on.)
Government, properly understood, does have a positive role to play, i.e., it should be here to protect, but never to persecute patients nor deny them valuable medicine for unsound reasons.
#MMJ #WHO #CBD #UTpol #UtahNext #TRUCE
See full article – WHO Report Finds No Public Health Risks Or Abuse Potential For CBD
